Learn more

TOXIMED GMBH

Overview
  • Total Patents
    70
About

TOXIMED GMBH has a total of 70 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are LIMONOV VIKTOR LVOVICH, HUMAN RT and CHAUDHARY MANU.

Patent filings in countries

World map showing TOXIMED GMBHs patent filings in countries

Patent filings per year

Chart showing TOXIMED GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Weickmann Dirk 66
#2 Weikmann Dirk 4

Latest patents

Publication Filing date Title
WO2007065925A2 Composition for treatment of melanomas and skin disorders and cosmetic care product
WO2007060252A2 Pharmaceutical active ingredient for treating hepatitis, borreliosis and multiple sclerosis
EP1782817A1 Pharmaceutical preparation made from the oral secretion of Varanus, Timon, Lacerta and/or Podarcis for tumour treatment
EP1754486A2 Pharmaceutical Substance for the treatment of Hepatitis, Borreliosis and Multiple Sclerosis
DE102006013727A1 Composition, useful for e.g. caring of skin and/or for removing skin impurities, comprises an aqueous solution, saturated with fruit sugar; and an unpurified toxin obtained from spiders of the species e.g. Ischnocolus, and bee's honey
DE102005060932A1 Pharmaceutical composition for the treatment of tumors and certain viral diseases
DE102005058455A1 Composition, useful for e.g. caring of skin and/or for removing skin impurities, comprises an aqueous solution, saturated with fruit sugar; and an unpurified toxin obtained from spiders of the species e.g. Ischnocolus, and bee's honey
DE102005057040A1 Pharmaceutical active substance, useful to treat diseases caused by Lassa virus and Filovirus, comprises at least unpurified glandular secretion obtained from Diplopoda animals
DE102005056513A1 Pharmaceutical active substance for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises an unpurified gland secretion obtained from animals of the class Diplopoda
DE102005054918A1 Pharmaceutically active substance, useful for treating tumor diseases, comprises a non-purified poison aggregate obtained from animals of the species Sicarius, preferably of the species oweni
DE102005054688A1 Pharmaceutically active substance, useful to treat tumor diseases, comprises unpurified saliva obtained from animals of the genus Varanus, Timon, Lacerta and/or Podarcis
DE102005053673A1 Pharmaceutically active substance, useful to treat tumor diseases, comprises unpurified saliva obtained from animals of the genus Varanus, Timon, Lacerta and/or Podarcis
DE102005053213A1 Pharmaceutically active substance, useful to treat tumor diseases, comprises unpurified saliva obtained from animals of the genus Varanus, Timon, Lacerta and/or Podarcis
DE102005038768A1 Pharmaceutical active substance for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises an unpurified gland secretion obtained from animals of the class Diplopoda
DE102005033645A1 Pharmaceutical drug combination for the treatment of multiple sclerosis
DE102005027665A1 Pharmaceutical agent for overcoming the blood-brain barrier in combination with a drug derived from biogenic toxins against brain tumors
DE102005027478A1 Active substance, useful for treating tumors in renal tissue, comprises a peptide toxin, a substance, homeopathic Tarantula D4 in sodium chloride solution and saturated solution of poison cocktail of spiders of Loxoscele laeta
DE102005011111A1 Pharmaceutical composition comprising dendritic cells, useful for treating tumors, especially of the skin, where cells are loaded with animal toxins, formulated with a homeopathic component
DE102005004752A1 Pharmaceutical agent for the treatment of multiple sclerosis and AIDS
DE102004046990A1 Pharmaceutical agent for strengthening the immune system